A multicenter collaboration led by the Bellvitge Biomedical Research Institute (IDIBELL) - Institut Català d'Oncologia (ICO) ...

Extended cash runway into late 2027, beyond a potentially registration-enabling azenosertib data readout from DENALI Part 2Planned workforce ...

JonesResearch initiated coverage of OnKure Therapeutics (OKUR) with a Buy rating and $32 price target. The clinical stage precision oncology ...

I agree with Trump's HHS nominee on the dangers of ultraprocessed foods, but please don’t replace all your seed oils with ...

Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous ...

Having leaned so hard on defending democracy during the campaign only to see voters narrowly choose the autocrats, Democrats ...

The Trump administration tried to calm the waters after stakeholders, lobbyists and lawmakers scrambled to make sense of the ...

Exelixis, Inc. (Nasdaq: EXEL) announced today that its fourth quarter and full year 2024 financial results will be released ...

Jordan Spieth, Justin Rose, Francesco Molinari and Gary Koch are some boldface names, but the golfers who pulled off some of ...

Among other things, the move threatens programs and aid that millions in the US rely on. As we rise to meet an era of ...

Hollywood awards season is here, which means we will be reminded of how difficult things are for cinemas. They face rising ...

Each one of the 26 respondents who brought documentary features to Sundance in 2025 has their own fascinating set of ...